Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypes.
Lebedev T, Vagapova E, Spirin P, Rubtsov P, Astashkova O, Mikheeva A, Sorokin M, Vladimirova U, Suntsova M, Konovalov D, Roumiantsev A, Stocking C, Buzdin A, Prassolov V.
Lebedev T, et al.
Oncogene. 2021 Nov;40(44):6258-6272. doi: 10.1038/s41388-021-02018-7. Epub 2021 Sep 23.
Oncogene. 2021.
PMID: 34556815
Free PMC article.